Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-κB

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1167-1175

  Tafani, Marco ^a   Schito, Luana ^a,b   Pellegrini, Laura ^a   Villanova, Lidia ^a   Marfe, Gabriella ^c   Anwar, Tahira ^d   Rosa, Roberta ^e   Indelicato, Manuela ^f   Fini, Massimo ^f   Pucci, Bruna ^f   Russo, Matteo A ^a,f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PURINERGIC P2X7R RECEPTOR; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE SILENCING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HYPOXIA; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 79961174606     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr101     Document Type: Article

References (49)

1. Semenza,G.L. (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE, 407, cm8.
2. Irwin,D.C. et al. (2009) A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic. Biol. Med., 47, 55-61.
3. Song,I.S. et al. (2009) Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer. Exp. Mol. Med., 41, 51-58.
4. Pichiule,P. et al. (2007) Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J. Biol. Chem., 282, 36330-36340.
5. Kono,H. et al. (2008) How dying cells alert the immune system to danger. at. Rev. Immunol., 8, 279-289.
6. Ramasamy,R. et al. (2009) RAGE: therapeutic target and biomarker of the nflammatory response-the evidence mounts. J. Leukoc. Biol., 86, 505-512.
7. Ohashi,K. et al. (2010) Advanced glycation end products enhance monocyte activation during human mixed lymphocyte reaction. Clin. Immunol., 134, 345-353.
8. Hasegawa,T. et al. (2003) The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages. Atherosclerosis, 171, 211-218.
9. Zhou,Z. et al. (2006) Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med., 203, 1067-1080.
10. Kuniyasu,H. et al. (2002) Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J. Pathol., 196, 163-170.
11. Kuniyasu,H. et al. (2003) Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol. Rep., 10, 445-448.
12. Vicente Miranda,H. et al. (2010) The sour side of neurodegenerative disorders: the effects of protein glycation. J. Pathol., 221, 13-25.
13. Kim,W. et al. (2005) Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. Ann. N. Y. Acad. Sci., 1043, 553-561.
14. Logsdon,C.D. et al. (2007) RAGE and RAGE ligands in cancer. Curr. Mol. Med., 7, 777-789.
15. Gebhardt,C. et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med., 205, 275-285.
16. Sparvero,L.J. et al. (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med., 7, 17.
17. Riehl,A. et al. (2009) The receptor RAGE: bridging inflammation and cancer. Cell Commun. Signal., 7, 12.
18. Ravenna,L. et al. (2009) Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate, 69, 1245-1255.
19. Tafani,M. et al. (2010) Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci., 4, 1014-1023.
20. Abe,R. et al. (2008) AGE-RAGE system and carcinogenesis. Curr. Pharm. Des., 14, 940-945.
21. Taguchi,A. et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature, 405, 354-360.
22. North,R.A. (2002) Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
23. Surprenant,A. et al. (2009) Signaling at purinergic P2X receptors. Annu. Rev. Physiol., 71, 333-359.
24. Amstrup,J. et al. (2003) P2X7 receptor activates extracellular signalregulated kinases ERK1 and ERK2 independently of Ca2+ influx. Biochem. J., 374, 51-61.
25. Jacobson,K.A. et al. (2006) Agonists and antagonists for P2 receptors. Novartis Found. Symp., 276, 58-68.
26. Zhang,X. et al. (2009) The role of P2X7 receptor in ATP-mediated human leukemia cell death: calcium influx-independent. Acta Biochim. Biophys. Sin. (Shanghai), 41, 362-369.
27. Gorodeski,G.I. (2009) P2X7-mediated chemoprevention of epithelial cancers. Expert Opin. Ther. Targets, 13, 1313-1332.
28. Wen,L.T. et al. (2003) Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor. Br. J. Pharmacol., 140, 1009-1018.
29. Fu,W. et al. (2009) Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice. BMC Cancer, 9, 114.
30. Bernardo,A.A. et al. (2006) Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart. Mol. Cell. Biochem., 289, 111-124.
31. Di Virgilio,F. et al. (2009) P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal., 5, 251-256.
32. Adinolfi,E. et al. (2009) Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis. J. Biol. Chem., 284, 10120-10128.
33. Ortega,F. et al. (2010) P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons. Cell. Mol. Life Sci., 67, 1723-1733.
34. Tafani,M. et al. (2011) Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J Neuroinflammation, 8, 32.
35. Karin,M. et al. (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310.
36. Rius,J. et al. (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 453, 807-811.
37. Schmid,J.A. et al. (2008) IkappaB kinase beta (IKKbeta/IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev., 19, 157-165.
38. Lin,Y. et al. (2010) The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin. Ther. Targets, 14, 45-55.
39. Riuzzi,F. et al. (2007) RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth. Am. J. Pathol., 171, 947-961.
40. Ranzato,E. et al. (2010) Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via rage-dependent ERK1/2 activation. Cell Biochem. Biophys., 57, 9-17.
41. Touré,F. et al. (2008) Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem. J., 416, 255-261.
42. Jacques-Silva,M.C. et al. (2004) P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br. J. Pharmacol., 141, 1106-1117.
43. Mistafa,O. et al. (2008) Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells. Biochem. Biophys. Res. Commun., 365, 131-136.
44. Le Stunff,H. et al. (2007) P2X7 receptor-mediated phosphatidic acid production delays ATP-induced pore opening and cytolysis of RAW 264.7 macrophages. Cell Signal., 19, 1909-1918.
45. Lépine,S. et al. (2006) ATP-induced apoptosis of thymocytes is mediated by activation of P2 X 7 receptor and involves de novo ceramide synthesis and mitochondria. Biochim. Biophys. Acta, 1761, 73-82.
46. Raymond,M.N. et al. (2006) Involvement of de novo ceramide biosynthesis in macrophage death induced by activation of ATP-sensitive P2X7 receptor. FEBS Lett., 580, 131-136.
47. Korcok,J. et al. (2004) Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J. Bone Miner. Res., 19, 642-651.
48. Wei,W. et al. (2008) Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett., 260, 79-87.
49. Solini,A. et al. (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology, 149, 389-396.